Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for PH-797804

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for PH-797804?

PH-797804 is an investigational drug.

There have been 14 clinical trials for PH-797804. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2008.

The most common disease conditions in clinical trials are Lung Diseases, Pulmonary Disease, Chronic Obstructive, and Lung Diseases, Obstructive. The leading clinical trial sponsors are Pfizer and [disabled in preview].

Recent Clinical Trials for PH-797804
A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804PfizerPhase 1
A Study to Investigate the Effect of PH-797804 on QTc IntervalPfizerPhase 1
A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804PfizerPhase 1

See all PH-797804 clinical trials

Clinical Trial Summary for PH-797804

Top disease conditions for PH-797804
Top clinical trial sponsors for PH-797804

See all PH-797804 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.